Citi Pharma Limited (PSX:CPHL)

Pakistan · Delayed Price · Currency is PKR

61.66

-0.38 (-0.61%)

At close: Oct 16, 2026

Citi Pharma Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	208.82	603.55	87.9	54.61	27.48
Short-Term Investments	136.04	919.59	1,222	1,393	1,660
Trading Asset Securities	3.38	66.5	108.81	132.36	312.12
Cash & Short-Term Investments	348.24	1,590	1,418	1,580	2,000
Cash Growth	-78.09%	12.08%	-10.26%	-20.97%	-34.96%
Accounts Receivable	3,470	3,078	2,197	1,882	1,402
Other Receivables	183.81	150.02	203.26	96.29	45.77
Receivables	3,654	3,228	2,400	1,978	1,447
Inventory	3,714	3,930	3,203	2,609	1,692
Other Current Assets	1,009	723.98	613.03	415.98	458.15
Total Current Assets	8,725	9,472	7,635	6,584	5,597
Property, Plant & Equipment	9,255	8,688	3,530	3,122	2,258
Long-Term Accounts Receivable	-	-	-	23.65	-
Other Long-Term Assets	279.98	279.98	274.76	254.54	272.06
Total Assets	18,260	18,439	11,439	9,984	8,127

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Accounts Payable	3,479	3,234	3,374	1,938	1,618
Accrued Expenses	32.79	280.74	216.54	206.62	149.67
Short-Term Debt	2,870	2,869	1,437	1,768	521.57
Current Portion of Long-Term Debt	56.42	-	12.86	55.88	160.69
Current Portion of Leases	28.39	15.8	5.42	5.67	4.77
Current Income Taxes Payable	484.41	519.68	470.83	393.19	404.18
Current Unearned Revenue	-	56.1	0.58	3.04	14.51
Other Current Liabilities	3.44	330.23	83.03	82.1	137.28
Total Current Liabilities	6,954	7,305	5,599	4,453	3,010
Long-Term Debt	57.24	-	-	8.54	250.17
Long-Term Leases	87.87	64.86	-	4.37	6.27
Long-Term Unearned Revenue	-	-	-	0.58	32.17
Pension & Post-Retirement Benefits	-	99.7	82.62	50.34	31.94
Long-Term Deferred Tax Liabilities	-	102.07	124.09	94.24	82.3
Other Long-Term Liabilities	326.83	-	-	-	-
Total Liabilities	7,426	7,572	5,806	4,611	3,413

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Common Stock	2,285	2,285	2,285	2,285	2,285
Additional Paid-In Capital	1,392	1,392	1,392	1,392	1,392
Retained Earnings	1,773	1,807	1,648	1,388	728.54
Comprehensive Income & Other	5,385	5,385	309.29	309.29	309.29
Shareholders' Equity	10,834	10,868	5,633	5,373	4,714
Total Liabilities & Equity	18,260	18,439	11,439	9,984	8,127

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Total Debt	3,100	2,950	1,455	1,843	943.48
Net Cash (Debt)	-2,751	-1,360	-36.55	-262.2	1,056
Net Cash Growth	-	-	-	-	-61.65%
Net Cash Per Share	-12.04	-5.95	-0.16	-1.15	4.66
Filing Date Shares Outstanding	228.46	228.46	228.46	228.46	228.46
Total Common Shares Outstanding	228.46	228.46	228.46	228.46	228.46
Working Capital	1,770	2,166	2,035	2,131	2,586
Book Value Per Share	47.42	47.57	24.66	23.52	20.63
Tangible Book Value	10,834	10,868	5,633	5,373	4,714
Tangible Book Value Per Share	47.42	47.57	24.66	23.52	20.63
Land	6,940	6,940	1,865	1,865	1,421
Buildings	776.96	673.95	661.56	485.03	309.33
Machinery	2,343	1,758	1,525	1,194	915.01
Construction In Progress	67.89	49.11	130.04	70.39	14.33